Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

NCT02842021 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

283

Enrollment

INDUSTRY

Sponsor class

Stopped Failed to meet success criteria

Conditions

Tinea Pedis

Interventions

DRUG: S2G6T-1
DRUG: S2G6T-2
DRUG: S2G6T-3
DRUG: S2G6T-4

Sponsor

Sol-Gel Technologies, Ltd.